---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-25-000135"
form_type: "8-K/A"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2025-12-05T23:59:59+00:00"
generated_at: "2026-05-16T14:15:32.313188+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avanos eliminates CCO and GC roles; final severance includes full vesting of James's 16,300 RSUs

## Summary
- Company eliminated Chief Commercial Officer and General Counsel positions effective Dec 1, 2025 as part of restructuring.
- Kerr Holbrook (CCO) and Mojirade James (GC) terminated; responsibilities reallocated.
- Severance: Holbrook $1,535,417; James $1,425,665; plus COBRA, prorated bonuses, equity vesting.
- 16,300 time-based RSUs granted to James on April 22, 2025 vested fully on Dec 1, 2025.
- Unvested awards treated as retirement; time-based PRSUs pro-rata vested, performance-based vest at end.

## SEC filing metadata
- accession: 0001606498-25-000135
- form_type: 8-K/A
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2025-12-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649825000135/0001606498-25-000135-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649825000135/avns-20251021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-25-000135
- JSON: https://secwatch.observer/filing/0001606498-25-000135.json
- Plain text: https://secwatch.observer/filing/0001606498-25-000135.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.